Table 1 Factor loadings for side effect factors
From: Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D
System | Item | GSE | Tolerability | Dizziness | Sexual | Visionhearing |
---|---|---|---|---|---|---|
GI | Diarrhea | 0.24 | ||||
Constipation | 0.27 | |||||
Dry mouth | 0.38 | |||||
Nausea/vomiting | 0.31 | |||||
GI tolerability | 0.55 | |||||
Heart | Palpitations | 0.29 | ||||
Dizziness on standing | 0.58 | 0.83 | ||||
Chest pain | 0.35 | |||||
Heart tolerability | 0.58 | 0.74 | ||||
Skin | Rash | 0.23 | ||||
Increased perspiration | 0.3 | |||||
Itching | 0.38 | |||||
Dry skin | 0.35 | |||||
Skin tolerability | 0.49 | |||||
CNS | Headache | 0.37 | ||||
Tremors | 0.32 | |||||
Poor coordination | 0.43 | |||||
Dizziness | 0.56 | 0.68 | ||||
CNS tolerability | 0.60 | |||||
VisHear | Blurred vision | 0.44 | 0.65 | |||
Ringing in ears | 0.35 | 0.63 | ||||
Eyesear tolerability | 0.51 | 0.92 | ||||
GenUrin | Difficulty urinating | 0.25 | ||||
Painful urination | 0.21 | |||||
Menstrual irregularity | 0.08 | |||||
Frequent urination | 0.33 | |||||
GenUrin. tolerability | 0.45 | |||||
Sleep | Difficulty sleeping | 0.3 | ||||
Sleeping too much | 0.07 | |||||
Sleep tolerability | 0.42 | |||||
Sex | Loss of sexual desire | 0.26 | 0.65 | |||
Trouble achieving orgasm | 0.18 | 0.56 | ||||
Trouble with erections | 0.22 | 0.44 | ||||
Sex tolerability | 0.35 | 0.88 | ||||
α | 0.74 | 0.72 | 0.80 | 0.71 | 0.75 |